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ABSTRACT
Functional genomics requires structural and func-
tional studies of a large number of proteins. While
the production of proteins through over-expression
in cultured cells is a relatively routine procedure, the
subsequent protein purification from the cell lysate
often represents a significant challenge. The most
direct way of protein purification from a cell lysate is
affinity purification using an affinity probe to the
target protein. It is extremely difficult to develop
antibodies, classical affinity probes, for a protein
in the cell lysate; their development requires a
pure protein. Thus, isolating the protein from the
cell lysate requires antibodies, while developing
antibodies requires a pure protein. Here we resolve
this loop problem. We introduce AptaPIC, Aptamer-
facilitated Protein Isolation from Cells, a technology
that integrates (i) the development of aptamers for
a protein in cell lysate and (ii) the utilization of the
developed aptamers for protein isolation from the
cell lysate. Using MutS protein as a target, we dem-
onstrate that this technology is applicable to the
target protein being at an expression level as low
as 0.8% of the total protein in the lysate. AptaPIC
has the potential to considerably speed up the
purification of proteins and, thus, accelerate their
structural and functional studies.
INTRODUCTION
As we entered the post-genomic era, the focus has shifted
from the analysis of genetic sequences to structural and
functional studies of the proteins they encode. The fast
progress in such studies requires the production of a
large number of proteins in a pure form. Recombinant
proteins are typically produced by their over-expression
in cultured cells followed by aﬃnity puriﬁcation from
the cell lysate (1). While protein expression in cells is a
well developed and relatively generic procedure, the aﬃn-
ity puriﬁcation of the protein from the cell lysate remains
a lengthy and labor-intensive procedure, which limits the
production of new proteins.
Usually for the purpose of aﬃnity puriﬁcation, a pro-
tein is genetically fused with a generic aﬃnity tag and the
resultant fusion protein (the protein plus the tag) is iso-
lated from the cell lysate using an aﬃnity probe for the
tag (2). It is never clear a priori whether the tag will aﬀect
the protein. The exogenous nature of the tag may intro-
duce unpredictable changes such as: changes in protein
conformation that can lead to alteration of the protein’s
biological activity, decreased protein yield and toxicity (3).
Moreover, it is often diﬃcult to eﬃciently cleave the
tag without fragmenting the target protein. Using the
tag would be unnecessary if an aﬃnity probe, such as an
antibody, was available for the protein itself. However,
antibodies are usually developed for a puriﬁed protein;
development of antibodies for a protein in cell lysate is
so laborious and time consuming that this possible
approach did not ﬁnd a wide application, if any (4).
Aptamers are synthetic oligonucleic acid molecules that
bind their targets with high aﬃnity and speciﬁcity (5–7),
and can substitute antibodies in numerous applications
(8–11). DNA aptamers are aﬃnity ligands selected
in vitro by diﬀerent aﬃnity methods from large combina-
torial libraries of random DNA sequences (naive libraries)
(12). Brieﬂy, a naive DNA library is mixed with a target
protein. DNA bound to the target is separated from
unbound DNA and ampliﬁed by PCR to produce an
aptamer-enriched DNA library. The procedure is repeated
several times (rounds) starting with the enriched library
obtained in the previous round. When aﬃnity of the
enriched library to the target stops improving with
additional rounds of enrichment, the selection is
stopped and an enriched DNA library with the best
aﬃnity to the target is considered as a pool of aptamers.
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aptamers is often called systematic evolution of ligands
by exponential enrichment (SELEX). Here we use terms
‘aptamers’ and ‘DNA aptamers’ interchangeably. We also
use interchangeably terms ‘a round of aptamer selection’
and ‘a round of library enrichment’. Aptamers have
been previously selected for a variety of targets ranging
from metal ions (13), to whole cells (14), and have proven
to be dependable even in applications where antibodies
have failed (such as detection of a protein in an ultra-
wide concentration range or identiﬁcation of cell-speciﬁc
biomarkers) (15–17).
If aptamers are selected for a protein target in a cell
lysate, they can be immediately used as aﬃnity probes
for puriﬁcation of the target protein from the cell lysate.
This is especially important for the puriﬁcation of new
proteins for which established puriﬁcation procedures
are not available. To the best of our knowledge, aptamers
have never been developed from a naive DNA library
for a speciﬁc full-sizes protein in a complex mixture,
such as cell lysate, without any prior puriﬁcation of the
protein. Here, we introduce a new integrated procedure
for: (i) the development of DNA aptamers for a protein
target in cell lysate and (ii) application of the developed
aptamer pool for puriﬁcation of the target protein
from the cell lysate. We name this technique AptaPIC—
Aptamer facilitated Protein Isolation from Cells
(Figure 1). In the ﬁrst part of AptaPIC, an aptamer
pool is selected for a target protein that is present in
a cell lysate without any prior puriﬁcation of the target
protein. In the second part, the developed aptamer pool,
containing a very large number of individual aptamers,
is used as an aﬃnity probe for puriﬁcation of the target
protein from cell lysate (there is no need to sequence indi-
vidual aptamers).
In this proof-of-principle work, we used T. aquaticus
MutS, a recombinant prokaryotic protein expressed in
Escherichia coli (1), as a target for aptamer selection
from the E. coli cell lysate. While one may think that a
protein that has DNA binding as its biological function
may be more susceptible to aptamer development than
a protein that does not have such a function, we argue
that this assumption does not have suﬃcient evidence. In
fact, the literature data suggests that DNA/RNA-binding
proteins are no better targets for aptamer development
than non-DNA/RNA-binding proteins (see Supplemen-
tary Data).
A recombinant protein expressed in E. coli may consti-
tute up to 40–50% of the total bacterial protein (18).
Depending on the nature of the protein none, some, or
most of the recombinant protein may be present in insol-
uble aggregates—inclusion bodies. T. aquaticus MutS, the
target of our selection, was previously recombinantly
expressed in E. coli at a high level; the vast majority
of which was shown to be in the soluble fraction (1). To
provide a more challenging scenario of low-level expres-
sion, we demonstrated that library enrichment for binding
MutS could be achieved with MutS being only at a level
of 0.8% of the total protein in the cell lysate. To have
this low and controlled level of MutS in the cell lysate,
we added T. aquaticus MutS, recombinantly expressed
in E. coli and puriﬁed from the E. coli cell lysate, to the
MutS-free E. coli cell lysate. Adding MutS into the E. coli
cell lysate rather than expressing it, is not expected to have
an adverse eﬀect because the protein was originally
expressed in E. coli. Moreover, it provided us with the
ﬂexibility required for the study of aptamer selection for
MutS present in the cell lysate at diﬀerent levels.
Aptamers have been previously developed for com-
plex targets such as mixtures of proteins and intact cells
(17,19–21), but never before for a target in a whole-cell
lysate. Cell lysate contains three groups of proteins that
can interfere with aptamer selection. The ﬁrst group is
proteases and nucleases that can degrade the target pro-
tein and aptamers, respectively. The second group is
DNA-binding proteins that can ruin the selection by non-
speciﬁc binding to DNA and contaminating the obtained
pools with non-aptamers. The third group is highly abun-
dant non-target proteins, which could become predomi-
nant targets in aptamer selection. The ﬁrst two groups
of proteins do not interfere with aptamer selection when
using intact cells as targets. Their presence in cell lysate,
however, makes aptamer selection for a target protein
in cell lysate considerably more challenging than selection
of aptamers for cell-surface proteins on intact cells. Here,
we demonstrate that aptamers can be selected for a pro-
tein in the cell lysate if the above-listed problems are
solved. We also propose two ways of obtaining target-
speciﬁc aptamers for a protein in cell lysate. In the ﬁrst
way, target-speciﬁc aptamers are obtained in consecutive
rounds of positive selection; this is possible if the target
protein is the predominant one in the cell lysate. In the
second way, target-speciﬁc aptamers are obtained by a
combination of regular (positive) selection with negative
selection against a target-free cell lysate. The latter
removes non-target-speciﬁc aptamers. For a level of
5% MutS, we conducted a complete AptaPIC process.
Figure 1. Aptamer-facilitated protein isolation from cells (AptaPIC). (i)
denotes aptamer selection by consecutive rounds of positive selection.
(ii) denotes aptamer selection with alternating positive and negative
selection.
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Finally, we demonstrated the aﬃnity puriﬁcation of MutS




Thermostable DNA mismatch binding protein (MutS)
from Thermus aquaticus was kindly donated by
InterSciences (Markham, ON, Canada). Fused-silica
capillaries were purchased from Polymicro (Phoenix,
AZ). All solutions were prepared using the Milli-Q-quality
deionized water and ﬁltered through a 0.22mm ﬁlter
(Millipore, Nepean, ON, Canada). Recombinant Taq
DNA polymerase, buﬀer components and all other chemi-
cals were from Sigma-Aldrich (Oakville, ON, Canada)
unless otherwise stated.
DNA library, primers, scrambled DNA andmasking DNA
The naive DNA library contained a central random-
ized sequence of 40 nucleotides (nt) ﬂanked by 20-nt
primer hybridization sites (50-/FAM/-CTC CTC TGA
CTG TAA CCA CG-(N)40-GCA TAG GTA GTC CAG
AAG CC-30). A 6-carboxyﬂuorescein-labeled 50-primer
(50-/FAM/-CTC CTC TGA CTG TAA CCA CG-30) and
a biotinylated 30-primer (50-/Bio/-GGC TTC TGG ACT
ACC TAT GC-30) were used in PCR reactions for the
synthesis of double-labeled double-stranded DNA mole-
cules. For the purpose of biotinylating aptamers in the
pool, biotin-labeled 50-primer (50-/Bio/-CTC CTC TGA
CTG TAA CCA CG-30) and non-labeled 30-primer
(50-GGC TTC TGG ACT ACC TAT GC-30) were used
in the PCR reaction. The DNA library, PCR primers,
scrambled DNA (50-/FAM/-CTT CTG CCC GCC TCC
TTC CTG GTA AAG TCA TTA ATA GGT GTG GGG
TGC CGG GCA TTT CGG AGA CGA GAT AGG
CGG ACA CT-30), single stranded masking DNA
(50-CAA AAA ATG AGT CAT CCG GA-30) and
double stranded masking DNA (50-ATT ATT ATT ATT
ATT ATT ATT ATT ATT ATT ATT ATT ATT ATT
ATT ATT ATT ATT AT-30 and the complementary
strand) were custom-synthesized by IDT (Coraville, IA).
Cell lysatepreparation
E. coli BL21(DE3) were grown at 378C to a density
corresponding to an absorbance of 1.5–1.6at 600nm
measured in a cuvette with an optical path-length of
1cm. Cells were harvested by centrifugation at 5000 g
for 10min at 48C. Pelleted cells were resuspended in the
sonication buﬀer: 50mM Tris–HCl, 2.5mM MgCl2,5m M
KCl at pH 8.3 containing the protease inhibitors (PI)
cocktail as instructed by the manufacturer (Sigma
Aldrich, Oakville, ON, Canada). Bacterial lysates were
prepared by sonication on ice with 5s ‘on’/15-s ‘oﬀ’ inter-
vals for a total of 15min. Cell debris was pelleted by cen-
trifugation at 15000 g for 20min at 48C and removed.
Cell lysates were aliquoted and stored at –208C. The con-
centration of ‘total’ protein in the cell lysate was measured
by Bradford assay, using bovine serum albumin as a
standard.
Inhibition of proteolysis
To monitor the proteolysis of MutS in the cell lysate, the
lysate was prepared as described above, without addition
of the protease (PI) cocktail into the sonication buﬀer.
Sample containing 54mg/ml MutS, cell lysate (containing
972mg/ml of the total protein) and 12mg/ml trypsin was
incubated 3h at 458C with or without the addition of
the PI cocktail as instructed by the manufacturer. The
samples were analyzed on 15% SDS–PAGE with
Coomassie Blue staining.
Inhibition of DNA degradation, gel-capillary
electrophoresis (Gel-CE)
Samples containing 30nM ﬂuorescently labeled scrambled
DNA and cell lysate (containing 365mg/ml of the
total protein) were incubated for 15min at 258C with or
without addition of EGTA and 300nM masking DNA.
The samples were analyzed by gel capillary electrophoresis
(eCAP ssDNA 100-R Kit, Beckman Coulter, Mississauga,
ON, Canada) using a P/ACE MDQ apparatus (Beckman
Coulter, Mississauga, ON, Canada) equipped with a ﬂuo-
rescence detector; a 488nm line of an Ar-ion laser was
utilized to excite ﬂuorescence.
Non-equilibrium capillary electrophoresis of equilibrium
mixtures (NECEEM)
All NECEEM procedures were performed using the
following instrumental setup. CE was carried out with a
P/ACE MDQ apparatus (Beckman Coulter, Mississauga,
ON, Canada) equipped with a ﬂuorescence detector;
a 488nm line of an Ar-ion laser was utilized to excite
ﬂuorescence. Uncoated fused silica capillaries with an
inner diameter of 75mm and outer diameter of 360mm
were used. For the aptamer selection, an 80cm-long
(70cm to the detection window) capillary was utilized.
NECEEM-facilitated analysis of enriched DNA libraries
was carried in a 50cm-long (40cm to the detection
window) capillary.
Both the inlet and the outlet reservoirs contained
the electrophoresis run buﬀer (50mM Tris–acetate at
pH 8.3). The samples were injected into the capillary,
pre-ﬁlled with the run buﬀer, by a pressure pulse of
16s 1psi (13.4kPa) and 5s 0.5psi (3.4kPa) for apta-
mer selection and for NECEEM-facilitated aﬃnity analy-
sis, respectively. The length and the volume of the
corresponding sample plugs were 23mm and 101nl for
aptamer selections and 6mm and 26nl for NECEEM-
facilitated aﬃnity analysis, respectively. Electrophoresis
was carried out with a positive electrode at the injection
end of the capillary; the direction of the electroosmotic
ﬂow was from the inlet to the outlet reservoir.
Separation for aptamer selection was carried out by an
electric ﬁeld of 250V/cm; NECEEM aﬃnity analysis
was performed at 400V/cm. The temperature of the
capillary during the separation was maintained at 208C.
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mode by replacing the regular outlet reservoir with a frac-
tion collection vial containing 5mL of deionized water.
The capillary was rinsed with the run buﬀer solution
for 2min prior to each run. At the end of each run, the
capillary was rinsed with 100mM HCl for 2min and
100mM NaOH for 2min, followed by a rinse with
deionized water for 2min. After the fraction collection
step, the capillary was rinsed with RNase-away solution
for 1min to remove any remnants of DNA from the
capillary.
Selection of aptamers forprotein targetin cell lysate by
consecutive rounds ofpositive selection
The equilibrium mixture for NECEEM-based selection of
aptamers was prepared in the incubation buﬀer (50mM
Tris–HCl, 2.5mM MgCl2, 5mM KCl and 5mM EGTA at
pH 8.3) using the following two-step procedure. First, a
DNA library (an 88mM solution in the selection buﬀer)
was denatured by heating at 998C for 5min and immedi-
ately transferred on ice. Second, 1mlo f8 8 mM naive
DNA library was mixed with 40mM single stranded mask-
ing DNA, 50nM ﬂuorescein, cell lysate (containing
178mg/ml of the total protein) and a known concentration
of MutS (see section ‘Selection of Aptamers for MutS
Present in Cell Lysate at Diﬀerent Levels’). Finally the
mixture was incubated at 258C for 15min to obtain the
equilibrium mixture.
A 23mm-long (101nl) plug of the equilibrium mixture
was injected into the capillary pre-ﬁlled with the run
buﬀer; the plug contained approximately 5 10
12 mole-
cules of DNA. The injected equilibrium mixture was sub-
jected to NECEEM. In the beginning of NECEEM, the
electrophoresis was carried out with the outlet reservoir
containing 5ml of deionized water to collect bound frac-
tion of DNA. Fluorescein was used as a marker of the
right-hand side boundary of the fraction collection
window; the outlet reservoir was changed back to the
run buﬀer as soon as ﬂuorescein eluted from the capillary.
A fraction of DNA of approximately 4ml was collected
and ampliﬁed by PCR. In addition to the collected
DNA template, the PCR mixtures contained 50mM
KCl, 10mM Tris–HCl (at pH 8.6), 2.5mM MgCl2, all
four dNTPs (200mM each), primers (300nM each), and
0.05 unit/ml Taq DNA polymerase. The total volume of
the PCR reaction mixture was 50ml. The optimum number
of cycles for ampliﬁcation was determined by real-time
PCR as described elsewhere (22). The optimum number
of PCR cycles (14 cycles for the ﬁrst round of aptamer
selection) was conducted, with every cycle consisting of
melting at 948C for 30s, annealing at 568C for 15s, and
extension at 728C for 15s. The product of symmetrical
PCR was used as a template in asymmetrical PCR to pro-
duce single stranded DNA. The asymmetrical PCR mix-
ture contained 50mM KCl, 10mM Tris–HCl (at pH 8.6),
2.5mM MgCl2, all four dNTPs (200mM each), 50nM
biotinylated reverse primer, 1mM ﬂuorescently labeled
forward primer, 0.05 unit/ml Taq DNA polymerase, and
3ml of the symmetrical PCR product. The total volume
of the PCR reaction mixture was 50ml. Fifteen cycles of
PCR were carried out following the same temperature
protocol as for symmetrical PCR. Double-stranded
DNA produced in asymmetric PCR was removed using
streptavidin-coated magnetic beads (Pierce, Rockford,
IL). After pulling down the magnetic beads, the super-
natant was transferred onto a 30kDa molecular cut-oﬀ
ﬁlter (Millipore, Nepean, ON, Canada) to separate the
excess of primers from the PCR product. The obtained
enriched DNA libraries were subjected to NECEEM-
facilitated evaluation of their aﬃnity towards MutS-free
cell lysate and MutS.
The subsequent rounds of aptamer selection were
carried out following the same procedure with 1mlo f
enriched DNA library (concentration  200nM) used
instead of the naive DNA library and concentration of
masking DNA lowered to 300nM (instead of 40mM) in
the equilibrium mixture.
NECEEM-facilitated analysis of obtained
enriched DNA libraries
Progression of aptamer selection was monitored by
NECEEM-facilitated analysis of aﬃnities of the enriched
DNA libraries to MutS or MutS-free cell lysate. One
microliter of the obtained enriched DNA library (at a
concentration of approximately 200nM) was mixed with
300nM single-stranded masking DNA, the indicated con-
centration of MutS or cell lysate (containing 391mg/ml of
the total protein) in a total volume of 5ml. The equilibrium
mixture was incubated for 15min at 258C. A 5mm-long
(26nl) plug of the equilibrium mixture was injected by
pressure into the capillary pre-ﬁlled with the run buﬀer
and was subject to electrophoresis at 400V/cm. Aﬃnities
of the obtained enriched DNA libraries for MutS were
calculated as described elsewhere (23) (see Supplementary
Data).
Selection ofaptamers for MutSpresent in cell lysate
at differentlevels
In order to understand what was the lowest ratio of tar-
get protein to total protein in the sample that could still
allow selection of aptamers without the need of negative
selection, a series of aptamer selections were performed
for samples containing a ﬁxed amount of the cell lysate
and diﬀerent amounts of MutS. The equilibrium mixtures
were prepared as described above with addition of 100,
60, 40, 20, 16, 10, 1 or 0.1nM MutS to result in 5%,
3%, 2%, 1%, 0.8%, 0.5%, 0.05% or 0.005% of the
target protein from total sample protein, respectively.
The aptamer selections and analysis of the obtained
enriched DNA libraries were carried out essentially as
described in the section ‘Selection of Aptamers to
Protein Target in Cell Lysate by Consecutive Rounds of
Positive Selection’.
Protein isolation fromcell lysate
The aptamer pool obtained from the ﬁfth round of
aptamer selection was used to purify MutS from the
cell lysate. The aptamer pool was biotinylated in
asymmetric PCR ampliﬁcation in a mixture similar to
that indicated above but containing 1mM biotinylated
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To each 150ml of PCR mixture, 9ml of the aptamer pool
was added; 15 cycles of ampliﬁcation were carried out as
described above. For the control experiment, biotinylated
naive DNA library was prepared by ampliﬁcation of 9ml
of 50nM initial naive library in the same procedure.
Products of asymmetrical PCR were puriﬁed from primers
on 30kDa molecular weight cut-oﬀ ﬁlters. Because the
double stranded product of PCR was also biotinylated,
we could not purify the biotinylated ssDNA product
from dsDNA.
The entire product of PCR was mixed with 40mM
single-stranded masking DNA, 5mM double-stranded
masking DNA, cell lysate (containing 91.25mg/ml of
the total protein), and 200nM MutS in the incubation
buﬀer. The mixture was incubated for 15min at 258C.
Thirty microliters of 5mg/ml streptavidin-coated mag-
netic beads were added to each of the samples and the
mixture was incubated for another 10min at 258C. The
magnetic beads with the attached aptamers and proteins
were pulled down using a magnet and washed 3 times
with the incubation buﬀer. The unbound fraction was
combined with all three fractions collected after washings,
concentrated by evaporation of water in a vacufuge
(Vacufuge Concentrator 5301, Eppendorf, Germany)
and analyzed on SDS–PAGE with Coomassie Blue stain-
ing. To elute the bound protein from aptamers, the bound
fraction was re-suspended in the incubation buﬀer con-
taining 6M urea and incubated 15min at 258C. After
the incubation, magnetic beads were pulled down by a
magnet and supernatants of bound fractions were puriﬁed
from urea by centrifugation on a 5kDa molecular cut-oﬀ
ﬁlter at 7000r.p.m. for 15min at 48C and analyzed on
4–20% SDS–PAGE.
RESULTS AND DISCUSSION
Degradationof targetprotein and DNA in cell lysate
We ﬁrst studied protein and aptamer degradation in the
cell lysate. To monitor the integrity of MutS, we per-
formed SDS–PAGE of MutS after its incubation with a
cell lysate containing active and inhibited proteases. To
monitor degradation of DNA by nucleases we used a
ﬂuorescently labeled synthetic 80-base-long oligonucleo-
tide (the same length as aptamers) with a scrambled
sequence. The integrity of the DNA was monitored by
Gel-CE, which separates the original DNA molecules
from their degradation products. We also artiﬁcially
enhanced the proteolytic activity in the cell lysate by exter-
nally adding trypsin to the analyzed mixture. This was
done to mimic a scenario more challenging than proteo-
lytic degradation of MutS in the cell lysate. We showed
that the addition of a commercially available PI cocktail
(Sigma-Aldrich) to the cell lysate preserved MutS from
degradation for 3h, even in the presence of the external
protease (Figure 2A). This time was enough to complete
a round of aptamer selection; thus, the problem of protein
degradation was resolved.
Nuclease activity of the lysate, on the other hand, cannot
be inhibited by standard commercial nuclease inhibitors.
Figure 2. Three processes that interfere with aptamer development for a target protein in cell lysate: protein degradation (A), DNA degradation
(B) and binding of DNA by non-target components of cell lysate (C). (A) MutS degradation was analyzed by SDS–PAGE with Coomassie staining.
The four lanes (from left to right) in the gel image correspond to: (i) molecular weight standards ( 1000), (ii) MutS degraded by proteases in the cell
lysate, (iii) MutS rescued from proteolysis in the cell lysate by a protease inhibitor (PI) cocktail, and (iv) pure MutS. The samples analyzed contained
972mg/ml of cell lysate protein and 54mg/ml of MutS. (B) DNA degradation was analyzed by gel capillary electrophoresis (Gel CE) using a
scrambled 80-nt DNA as an experimental model. The three traces (from bottom to top) correspond to: (i) scrambled DNA degraded in cell
lysate, (ii) scrambled DNA rescued from the degradation in the cell lysate by masking DNA and EGTA and (iii) scrambled DNA as a control.
(C) Binding of DNA to non-target components of the cell lysate was studied by NECEEM using the scrambled DNA. The two traces (from bottom
to top) in (C) correspond to: (i) scrambled DNA bound to non-target components of the cell lysate and/or partially degraded DNA and (ii)
scrambled DNA rescued from binding and degradation by masking DNA. NECEEM was carried out in a 50-cm-long capillary at an electric
ﬁeld of 400V/cm with 50mM Tris–acetate at pH 8.3 as a run buﬀer.
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they contain proteases or protein modifying chemicals
that can degrade the target protein (in our aptamer
selection, we need to protect from degradation both the
target protein and DNA). An alternative way to inhibit
nucleases is the addition of a chelating agent such as
EGTA, and an excess of a masking DNA. EGTA sup-
presses nuclease activity by chelating Ca
2+, which some
nucleases require for their activity (24). The masking
DNA is DNA without a ﬂuorescent label and PCR
primer regions that competitively protects aptamers from
degradation by nucleases (17,25). When used together,
EGTA and masking DNA kept about 90% of the
aptamer intact for 3h of incubation with cell lysate
(Figure 2B). This 90% included DNA molecules that
were missing only 1–2nt (the split peak in Figure 2B,
second trace from the top). The missing 1–2nt do not pre-
vent the annealing of the primers to the partially degraded
DNA template; thus, this partially degraded DNA is
ampliﬁable by PCR and can be used in aptamer selection.
The nuclease activity can also be inhibited by solely using
masking DNA if the addition of a chelating agent such
as EGTA is undesirable; however, masking DNA should
be taken in a greater excess to the library than demon-
strated here.
Non-specific DNA binding incell lysate
We studied binding of the scrambled DNA by non-target
components of the cell lysate such as DNA-binding pro-
teins. This binding could interfere with selection of target-
speciﬁc aptamers as DNA molecules bound to non-target
components of the cell lysate would be collected as ‘bin-
ders’ and ampliﬁed along with aptamers. The scavenging
of aptamer by DNA-binding proteins can be suppressed
by using of an excess of the masking DNA (17,25). The
purpose of having an excess of the masking DNA is to
‘pre-occupy’ DNA-binding proteins and, thus, competi-
tively suppress this non-speciﬁc binding. To monitor the
DNA binding we analyzed a mixture of the scrambled
DNA and MutS-free cell lysate by NECEEM (26)
(Figure 2C). NECEEM separates molecular species
based on their charge to size ratios. While being a power-
ful method for studying protein–DNA binding, NECEEM
does not distinguish between products of DNA binding
and products of DNA degradation as they may have
charge to size ratios diﬀerent from that of free/intact
DNA. Accordingly, the multiple peaks observed in
Figure 2C to the left of the free/intact DNA peak
cannot be unambiguously assigned to complexes of
DNA with non-target proteins from the cell lysate. They
can also be products of DNA degradation. Nevertheless,
the addition of a 10-time excess of masking DNA over the
scrambled DNA suppressed DNA binding/degradation to
the undetectable level.
Potential aptamerselection forother proteins incell lysate
The last problem that can arise when selecting aptamers
to a target protein in cell lysate is the possibility of
aptamer selection for non-target molecules and obtaining
an aptamer pool with poor aﬃnity and speciﬁcity for
the target protein. This problem is usually solved by alter-
nating regular selection steps for a complex mixture con-
taining the target protein with negative selection (counter-
selection) steps for the sample containing all other com-
ponents without the target protein (17). Essentially, nega-
tive selection eliminates aptamers for non-target molecules
leaving only aptamers for the target molecule. Aptamers
are known to be more readily developed for the most
abundant proteins in the sample (27). Thus, we hypothe-
sized that the enrichment of a DNA library will take place
primarily with respect to the over-expressed protein and
negative selection may not be required to achieve a desired
speciﬁcity of aptamer pool to the target molecule. To test
this hypothesis, we conducted ﬁve rounds of aptamer
selection for the cell lysate containing 5% of MutS over
the total protein.
Aptamer selection starts with a naive DNA library. In
our case, the ﬂuorescently labeled 80-nt DNA library con-
sisted of 40-nt random region ﬂanked by 20-nt primer
hybridization regions. The naive library was mixed with
the cell lysate containing 5% MutS and incubated in the
presence of the excess of masking DNA. The equilibrium
mixture was subjected to NECEEM separation. We used
NECEEM for the partitioning of bound DNA from
unbound DNA. The separation mode of NECEEM used
here was free zone capillary electrophoresis in an uncoated
capillary in which both DNA and protein are moved
towards the negative electrode by the electroosmotic
ﬂow (EOF). In addition to the EOF, charged molecules
will have electrophoretic mobilities. The direction of the
electrophoretic mobility of positively charged molecules
is co-directed with that of the EOF. The direction of the
electrophoretic mobility of negatively charged molecules is
opposite to that of the EOF. DNA is heavily negatively
charged due to its sugar-phosphate backbone and as a
result, in free zone electrophoresis with positive electrode
at the inlet, DNA migrates slower than the majority of
proteins. Moreover, protein–DNA complexes also migrate
between the free protein and unbound DNA. We used
ﬂuorescein as a marker of the right-hand boundary of
the fraction collection window. Fluorescein is an ideal
marker for this purpose because the unbound DNA
library migrates slightly slower than ﬂuorescein. Collect-
ing a fraction up to ﬂuorescein allows as wide a fraction
collection window as possible ensuring, however, that
little unbound DNA is collected. The entire fraction
migrating faster than ﬂuorescein was collected to obtain
the bound DNA (Figure 3A). The collected DNA fraction
was ampliﬁed. For this purpose, we used tandem PCR.
The ﬁrst PCR was symmetrical PCR with equal amounts
of primers, the second—asymmetrical PCR where a for-
ward primer was in 20-time excess over a reverse primer.
After that, the PCR product was puriﬁed from double
stranded DNA, primers, polymerase and dNTPs. This
was the end of the ﬁrst round of aptamer selection. In
the second round, the enriched DNA library obtained in
the ﬁrst round was incubated with the MutS-containing
cell lysate and the procedure described above was
repeated. Five rounds of library enrichments were carried
out. The enriched libraries obtained in every round were
separately evaluated for their binding to pure MutS and
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NECEEM. To characterize the aﬃnity of the enriched
DNA libraries to MutS, we used EC50 (an eﬀective con-
centration of DNA at which a half of it is bound to the
target protein) (17) instead of a conventional equilibrium
dissociation constant, Kd. The latter can only be used for a
single interacting pair. As EC50 is not a constant, it should
always be accompanied by the concentration of a target
protein at which it was measured.
In only three rounds of aptamer selection, the aﬃnity
of the enriched DNA library to MutS improved 40 times
compared to that of the naive library (Figure 3B). Two
additional rounds of enrichment did not further improve
the aﬃnity of the enriched libraries to MutS (results not
shown). Interestingly, the aﬃnity of the enriched library
to the non-target components of the cell lysate remained
unchanged even after ﬁve consecutive rounds of positive
selection (Figure 3C). These results suggest that while
we were able to develop aptamers for the target protein
MutS, there was no accumulation of aptamers for non-
target components of the cell lysate. The demonstrated
experimental results indicate that when the target protein
is present at an over-expressed level, counter-selection
against the target-free cell lysate may be omitted because
no enrichment of the library takes place with regards
to the cell lysate components. One possible explanation
for this observation is that the concentration of MutS is
at least 10 times higher than that of the most abundant
protein in the cell lysate (according to SDS–PAGE). Thus,
MutS becomes a ‘leading’ target in the aptamer selection
process while the contribution of non-target molecules to
the obtained aptamer-enriched library becomes negligible.
The second way of obtaining target-speciﬁc aptamers
is the introduction of a step of negative selection against
a target-free cell lysate (17). Although for the speciﬁc case
presented in this work, the step of negative selection was
not required, as no enrichment of the library towards
components of the cell lysate took place, this could be
not true for diﬀerent targets at diﬀerent levels of expres-
sion. For cases when the amount of the target protein is
not suﬃciently high, it may be required to introduce the
negative selection step in order to obtain target-speciﬁc
aptamers (Supplementary Data).
Proteinisolation from cell lysate
As the aﬃnity of the enriched library did not signiﬁcantly
improve in the last two rounds of aptamer selection, the
aptamer pool obtained after the ﬁfth round of the selec-
tion was used for aptamer-mediated protein puriﬁcation.
Conventionally, after the aptamer pool is obtained,
individual aptamer clones are isolated, analyzed for their
aﬃnity to the target molecule, and a clone with the best
aﬃnity is chosen for further applications. The cloning
and screening steps are time-consuming (1–2 weeks) and
expensive. Screening one hundred clones could cost more
than a thousand dollars. Here, we propose skipping these
steps and using the entire enriched aptamer pool for aﬃn-
ity puriﬁcation of the target protein instead of individual
aptamers.
For the protein isolation, the aptamer pool was
biotinylated in asymmetrical PCR ampliﬁcation using a
biotin-labeled forward primer. The product of PCR
ampliﬁcation was puriﬁed with a molecular cut-oﬀ ﬁlter.
The ﬁnal biotinylated pool contained ssDNA (more than
99%) and dsDNA (less than 1%). To prevent the non-
speciﬁc binding of dsDNA to the components of the cell
lysate in the protein puriﬁcation step, we used the excess
of masking dsDNA in addition to masking ssDNA.
MutS-containing cell lysate was mixed with the biotiny-
lated aptamer pool in the presence of excess masking ds/ss
Figure 3. Selection of aptamers for MutS in the E. coli cell lysate by consecutive rounds of positive selection. (A) Aptamer collection window for
NECEEM-based selection of aptamers. The equilibrium mixture was injected into the capillary and electrophoresis was carried out in an 80-cm-long
capillary at a 250V/cm electric ﬁeld with 50mM Tris–acetate at pH 8.3 as a run buﬀer. The entire fraction migrating before ﬂuorescein was collected
for PCR ampliﬁcation of DNA contained in it. (B) Progression of selection with regards to MutS. A naive DNA library and enriched aptamer pools
were incubated with pure MutS and NECEEM was used to estimate EC50 values for 220nM MutS. The three traces (from bottom to top)
correspond to the mixture of MutS with (i) naive library, (ii) enriched DNA library after one round of aptamer selection and (iii) enriched DNA
library after three rounds of aptamer selection. (C) Progression of selection with regards to the MutS-free cell lysate. The naive DNA library and
enriched aptamer pools were incubated with MutS-free cell lysate and analyzed by NECEEM. The three traces (from bottom to top) correspond to
mixtures of MutS-free cell lysate with: (i) naive library, (ii) enriched DNA library after three rounds of aptamer selection and (iii) enriched DNA
library after ﬁve rounds of aptamer selection. In (B) and (C), NECEEM was carried out in a 50-cm-long capillary at an electric ﬁeld of 400V/cm
with 50mM Tris–acetate at pH 8.3 as a run buﬀer.
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magnetic beads were added and the mixture was incubated
for another 10min followed by the pull-down of the beads
by a magnet. The unbound fraction of the cell lysate
(the waste) was removed and analyzed by SDS–PAGE.
In the ﬁnal step of AptaPIC, the target protein was dis-
sociated from DNA aptamers and magnetic beads. There
is no universal solution for this step. Depending on the
application and the nature of the protein, the elution of
the immobilized protein could be carried out in a number
of ways: high temperature, treatment with high salt
concentration (14), metal ion chelating agents (28), pH
variation, ammonium sulfate precipitation of the protein,
treatment with urea (17), nuclease degradation of
aptamers, addition of an excess of a complementary
strand of the aptamer and even trypsinization of the pro-
tein for its mass spectrometric identiﬁcation. In our case,
we chose to elute the protein using 6M urea treatment of
the aptamer-bound fraction. The bound fraction was incu-
bated in 6M urea for 15min to dissociate aptamer-protein
complexes. Urea was removed form the eluted fraction by
size-exclusion ﬁltration before the analysis of the fraction
on SDS–PAGE (Figure 4). As a control, we showed that
the biotinylated naive library did not isolate MutS from
the cell lysate. The presence of the band, corresponding to
MutS in the aptamer-bound fraction, demonstrated the
aﬃnity of the developed aptamers for MutS. The near
absence of the bands, corresponding to all other proteins,
proved that the developed aptamers were very speciﬁc
towards MutS. MutS sample obtained as a result of puri-
ﬁcation with aptamers developed by AptaPIC was 99%
pure; this represents 4.9-fold puriﬁcation (maximum pos-
sible fold puriﬁcation being 5.0). The percentage yield of
MutS after one step of aﬃnity puriﬁcation using the
developed aptamers was around 70%. We foresee that
this percentage yield can be improved by using higher
amount of aptamers in the puriﬁcation step.
While urea is a soft protein denaturant, it can denature
some proteins irreversibly. To verify the activity of the
puriﬁed MutS after urea treatment we tested MutS bind-
ing to its synthetic DNA aptamer that was previously
obtained (29) (results not shown). Heat denatured MutS
did not possess an aﬃnity to its synthetic aptamer; MutS
eluted by urea on the other hand showed the expected
aﬃnity to the synthetic aptamer, suggesting that the
protein was in its native state. The aptamer-facilitated
puriﬁcation of MutS delivered the protein with high
purity and in the native state. These results clearly dem-
onstrate that AptaPIC can be reliably used for puriﬁcation
of a target protein from a cell lysate.
Selection ofaptamers for proteintarget present
at differentlevels in cell lysate
Here we demonstrated whole AptaPIC procedure on the
example of 5% MutS in E. coli cell lysate without the need
of introduction of the negative selection step. Omitting
the step of negative selection signiﬁcantly shortens the
length of AptaPIC and adds some additional level of con-
trol over the procedure. However, to be able to omit the
negative selection step, it is necessary that the target pro-
tein be at a high enough level of expression to become
the predominant target of aptamer selection. To ﬁnd out
the lowest amount of MutS that allowed the development
of aptamers without the need of negative selection, we
performed a series of aptamer selections for cell lysate
containing diﬀerent amounts of MutS. Only the ﬁrst
round of aptamer selection (from the naive library) was
performed for each sample and the aﬃnities of the
obtained enriched libraries to pure MutS were assessed
by NECEEM. We considered that the development of
aptamers for the target was possible if the aﬃnity of the
enriched library (obtained after one round of positive
aptamer selection) to MutS was better than that of the
naive library. In other words, the aptamer selection was
possible if an EC50 value of the enriched library was lower
than that of the naive library. The EC50 value for the naive
library was approximately 2.2mM for 220nM MutS. The
EC50 values of the enriched libraries obtained for diﬀerent
MutS concentrations in the cell lysate are presented in
Figure 5. The lowest amount of MutS that resulted in
the improvement of aﬃnity of the enriched library to
MutS compared to that of the naive library was 0.8%
MutS with respect to the total protein in the cell lysate.
When the ratio of MutS to total protein was further
lowered, aptamer selection for MutS did not succeed. In
fact, EC50 values of the enriched libraries obtained
for samples with less than 0.8% MutS were higher than
that of the naive library. The most likely explanation for
the latter observation is that the aptamer selection took
place for non-target components of the cell lysate and
decreased the aﬃnity of the obtained enriched library
to the MutS protein. The results demonstrated in
Figure 5 suggest that aptamers could be obtained even
for a relatively poorly expressed recombinant protein
Figure 4. SDS–PAGE with Coomassie staining of aﬃnity pull-down of
MutS from the E. coli cell lysate using the aptamers developed by
AptaPIC. The lanes from left to right correspond to: (i) molecular
weight standards ( 1000); (ii) pure MutS; (iii) MutS-containing cell
lysate, the sample contained 91.25mg/ml and 18mg/ml of MutS; (iv)
MutS puriﬁcation using the naive DNA library, bound fraction; (v)
MutS puriﬁcation using the developed aptamer pool, bound fraction;
(vi) fraction bound to streptavidin-coated magnetic beads; (vii) MutS
puriﬁcation using the naive DNA library, unbound fraction; and
(viii) MutS puriﬁcation using the developed aptamer pool, unbound
fraction.
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protein is the most abundant in the cell lysate. It should
be noted that having a low amount of the target protein in
the cell lysate may result in contamination of the aptamer
pool with aptamers for non-target molecules. As a result,
the protein puriﬁcation using such aptamer pool can be
compromised.
CONCLUSIONS
Here we introduced a method for developing aptamers
for a target protein in crude cell lysate and puriﬁcation
of the target protein from the cell lysate using the obtained
aptamers. The feasibility of the method was demonstrated
on T. aquaticus MutS in E. coli cell lysate, however, we
foresee that this method can be extended to application
for any other protein for which the development of apta-
mers is possible. To conclude, we outline major features of
AptaPIC. Using the AptaPIC procedure, aptamers can
be developed for a protein, which is not available in a
pure form. The developed aptamers can be used for puri-
ﬁcation of the protein from a complex mixture. For the
successful generation of aptamers in a cell lysate, we found
solutions for: (i) the protection of the target protein and
potential aptamers from degradation by cell lysate pro-
teases and nucleases and (ii) the suppression of non-
speciﬁc DNA binding of lysate proteins to aptamers. As
demonstrated here, if the target protein is present at the
level of over-expression, aptamers can be successfully
generated in consecutive rounds of positive selection with-
out negative selections. If the amount of the target protein
is not suﬃciently high, the step of negative selection can
be added into the procedure. The developed aptamers
can then be used in the aﬃnity puriﬁcation of the target
protein from the cell lysate. Considering the extreme
complexity of cell lysate, AptaPIC can be extended to
potentially any biological mixture such as blood, urine
and others. AptaPIC facilitates the faster generation of
new recombinant proteins in pure form for their structural
and functional studies as well as for other biomedical
applications. Moreover, due to easier and lower cost of
their production, the aptamers obtained by AptaPIC can
be used as antibody surrogates in applications such as
western analysis, ﬂuorescent microscopy, and ﬂow
cytometry.
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